Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biophysical Journal|October 7, 2010
Probing intracellular motor protein activity using an inducible cargo trafficking assayLukas C Kapitein, Max A Schlager, Wouter A van der Zwan, et al.
European Journal of Endocrinology|August 14, 2014
GEPNETs update: Radionuclide therapy in neuroendocrine tumorsWouter A van der Zwan, Lisa Bodei, Jan Mueller-Brand, et al.
Endocrine-Related Cancer|March 22, 2017
Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateTessa Brabander, Wouter A van der Zwan, Jaap J M Teunissen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 3, 2011
NMDA receptor activation suppresses microtubule growth and spine entryLukas C Kapitein, Kah Wai Yau, Susana Montenegro Gouveia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2016
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotateHendrik Bergsma, Mark W Konijnenberg, Wouter A van der Zwan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2018
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacyLisa Bodei, Mark S Kidd, Aviral Singh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2019
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETestLisa Bodei, Mark S Kidd, Aviral Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine TumorsTessa Brabander, Wouter A van der Zwan, Jaap J M Teunissen, et al.
Pageof 1